UBS Group’s iRhythm Holdings IRTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-28,000
Closed -$2.08M 10163
2024
Q3
$2.08M Hold
28,000
﹤0.01% 3951
2024
Q2
$3.01M Hold
28,000
﹤0.01% 3344
2024
Q1
$3.25M Hold
28,000
﹤0.01% 3429
2023
Q4
$3M Sell
28,000
-9,000
-24% -$784K ﹤0.01% 3363
2023
Q3
$3.49M Buy
37,000
+7,000
+23% +$712K ﹤0.01% 2923
2023
Q2
$3.13M Hold
30,000
﹤0.01% 3062
2023
Q1
$3.72M Hold
30,000
﹤0.01% 2808
2022
Q4
$2.81M Hold
30,000
﹤0.01% 3036
2022
Q3
$3.76M Buy
+30,000
New +$4.33M ﹤0.01% 2611
2021
Q2
Sell
-2,300
Closed -$319K 9582
2021
Q1
$319K Sell
2,300
-500
-18% -$89.6K ﹤0.01% 5177
2020
Q4
$664K Buy
+2,800
New +$638K ﹤0.01% 4361

Other funds holding IRTC

UBS Group's IRTC Position: Q2 2026 in Review

UBS Group reduced its iRhythm Holdings (IRTC) stake by 15% in Q2 2026, selling an estimated $1.66M and leaving 77,665 shares worth $9.24M. The position accounts for ﹤0.01% of the portfolio, ranked #3533.

UBS Group first reported a position in IRTC in Q4 2016 and has held it in 39 quarters since. The position peaked at $27.2M in Q4 2025. 303 funds tracked by Wall St. Rank hold IRTC as of Q2 2026.

  • UBS Group held 77,665 shares of iRhythm Holdings worth $9.24M as of Q2 2026.
  • UBS Group sold 14,238 iRhythm Holdings shares in Q2 2026, an estimated $1.66M.
  • iRhythm Holdings made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #3533 holding.
  • UBS Group first reported a position in iRhythm Holdings in Q4 2016 and has held it in 39 quarters since.
  • UBS Group's iRhythm Holdings position peaked at $27.2M in Q4 2025.
  • 303 funds tracked by Wall St. Rank held iRhythm Holdings as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.